First National Trust CO Annovis Bio, Inc. Transaction History
First National Trust CO
- $2.44 Billion
- Q1 2025
A detailed history of First National Trust CO transactions in Annovis Bio, Inc. stock. As of the latest transaction made, First National Trust CO holds 15,000 shares of ANVS stock, worth $22,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$22,200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANVS
# of Institutions
50Shares Held
1.99MCall Options Held
348KPut Options Held
535K-
Vanguard Group Inc Valley Forge, PA648KShares$958,9210.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il215KShares$318,5060.0% of portfolio
-
Ubs Group Ag161KShares$238,0960.0% of portfolio
-
Geode Capital Management, LLC Boston, MA153KShares$225,8670.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$149,0490.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $12.1M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...